Notably, WHO grade 4 “astrocytoma, IDH-mutant” cases preferentially cluster with WHO grade 4 “glioblastoma, IDH-wildtype” rather than WHO grade 2–3 “astrocytoma, IDH-mutant”. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).